Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$106.13 - $120.89 $2.15 Million - $2.45 Million
20,300 Added 25.47%
100,000 $11.5 Million
Q2 2024

Aug 14, 2024

BUY
$92.57 - $107.37 $7.38 Million - $8.56 Million
79,700 New
79,700 $8.49 Million
Q4 2020

Feb 11, 2021

BUY
$78.07 - $94.43 $3.44 Million - $4.16 Million
44,100 Added 120.49%
80,700 $7.62 Million
Q3 2020

Nov 12, 2020

SELL
$82.14 - $91.0 $229,992 - $254,800
-2,800 Reduced 7.11%
36,600 $3.18 Million
Q2 2020

Aug 12, 2020

SELL
$80.93 - $91.1 $1.21 Million - $1.36 Million
-14,900 Reduced 27.44%
39,400 $3.44 Million
Q1 2020

May 13, 2020

SELL
$70.67 - $99.01 $3.69 Million - $5.17 Million
-52,200 Reduced 49.01%
54,300 $4.48 Million
Q4 2019

Feb 10, 2020

SELL
$84.35 - $95.37 $7.63 Million - $8.63 Million
-90,500 Reduced 45.94%
106,500 $10.1 Million
Q3 2019

Nov 14, 2019

BUY
$85.54 - $94.26 $10.9 Million - $12 Million
127,600 Added 183.86%
197,000 $17.1 Million
Q2 2019

Aug 14, 2019

BUY
$75.4 - $92.8 $3.17 Million - $3.91 Million
42,100 Added 154.21%
69,400 $6.34 Million
Q1 2019

May 15, 2019

SELL
$75.32 - $86.15 $1.22 Million - $1.4 Million
-16,200 Reduced 37.24%
27,300 $2.63 Million
Q4 2018

Feb 14, 2019

BUY
$73.66 - $82.02 $1.75 Million - $1.94 Million
23,700 Added 119.7%
43,500 $3.73 Million
Q3 2018

Nov 14, 2018

SELL
$66.94 - $77.43 $1.23 Million - $1.42 Million
-18,300 Reduced 48.03%
19,800 $1.71 Million
Q2 2018

Aug 14, 2018

SELL
$64.91 - $73.36 $1.31 Million - $1.48 Million
-20,200 Reduced 34.65%
38,100 $2.88 Million
Q1 2018

May 15, 2018

BUY
$70.39 - $84.15 $232,287 - $277,695
3,300 Added 6.0%
58,300 $4.71 Million
Q4 2017

Feb 14, 2018

BUY
$72.33 - $77.64 $1.66 Million - $1.79 Million
23,000 Added 71.88%
55,000 $4.62 Million
Q3 2017

Nov 14, 2017

BUY
$74.14 - $77.27 $2.37 Million - $2.47 Million
32,000
32,000 $2.75 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.